Pigment Cell & Melanoma Research

Cover image for Vol. 28 Issue 2

Early View (Online Version of Record published before inclusion in an issue)

Edited by: Marcus Bosenberg, Andrew E. Aplin and Heinz Arnheiter - Reviews Editor: Robert Kelsh

Impact Factor: 5.641

ISI Journal Citation Reports © Ranking: 2013: 2/61 (Dermatology); 27/203 (Oncology); 43/185 (Cell Biology)

Online ISSN: 1755-148X

VIEW

  1. 1 - 9
  1. Letters to the Editor

    1. Major association of vitiligo with HLA-A*02:01 in Japanese

      Ying Jin, Masahiro Hayashi, Pamela R. Fain, Tamio Suzuki, Kazuyoshi Fukai, Naoki Oiso, Atsushi Tanemura, Cherie L. Holcomb, Melinda Rastrou, Henry A. Erlich and Richard A. Spritz

      Article first published online: 17 FEB 2015 | DOI: 10.1111/pcmr.12356

      • image
  2. Original Articles

    1. You have full text access to this OnlineOpen article
      Melanoma tumors frequently acquire LRP2/megalin expression, which modulates melanoma cell proliferation and survival rates

      Rikke K. Andersen, Katrine Hammer, Henrik Hager, Julie N. Christensen, Maja Ludvigsen, Bent Honoré, Mai-Britt H. Thomsen and Mette Madsen

      Article first published online: 13 FEB 2015 | DOI: 10.1111/pcmr.12352

      • image
      • image
      • image
      • image
      • image
      • image
      • image
  3. Meeting Reports

    1. Developing core outcome set for vitiligo clinical trials: international e-Delphi consensus

      Viktoria Eleftheriadou, Kim Thomas, Nanja van Geel, Iltefat Hamzavi, Henry Lim, Tamio Suzuki, Ichiro Katayama, Tag Anbar, Marwa Abdallah, Laïla Benzekri, Yvon Gauthier, John Harris, Caio Cesar Silva de Castro, Amit Pandya, Boon Kee Goh, Cheng-Che E. Lan, Naoki Oiso, Ahmed Al Issa, Samia Esmat, Caroline Le Poole, Ai-Young Lee, Davinder Parsad, Alain Taieb, Mauro Picardo, Khaled Ezzedine and on behalf of the Vitiligo Global Issues Consensus Group (VGICG)

      Article first published online: 13 FEB 2015 | DOI: 10.1111/pcmr.12354

  4. Short Communications

    1. Increased circulating Th17 cells and elevated serum levels of TGF-beta and IL-21 are correlated with human non-segmental vitiligo development

      Li Zhou, Yu-Ling Shi, Kai Li, Iltefat Hamzavi, Tian-Wen Gao, Richard H. Huggins, Henry W. Lim and Qing-Sheng Mi

      Article first published online: 13 FEB 2015 | DOI: 10.1111/pcmr.12355

      • image
      • image
      • image
  5. Development & Stem Cells (DSC)

    1. Short Communications

      Detailed imaging and genetic analysis reveal a secondary BRAFL505H resistance mutation and extensive intrapatient heterogeneity in metastatic BRAF mutant melanoma patients treated with vemurafenib

      Marlous Hoogstraat, Christa G. Gadellaa-van Hooijdonk, Inge Ubink, Nicolle J. M. Besselink, Mark Pieterse, Wouter Veldhuis, Marijn van Stralen, Eelco F. J. Meijer, Stefan M. Willems, Michael A. Hadders, Thomas Kuilman, Oscar Krijgsman, Daniel S. Peeper, Marco J. Koudijs, Edwin Cuppen, Emile E. Voest and Martijn P. Lolkema

      Article first published online: 7 JAN 2015 | DOI: 10.1111/pcmr.12347

      • image
      • image
    2. Reviews

      You have free access to this content
  6. Signaling & Cell Biology (SCB)

    1. Reviews

      You have free access to this content
      MicroRNAs in melanocyte and melanoma biology

      Marina Mione and Anja Bosserhoff

      Article first published online: 6 JAN 2015 | DOI: 10.1111/pcmr.12346

      • image
      • image
    2. Original Articles

      MicroRNA and mRNA expression profiling in metastatic melanoma reveal associations with BRAF mutation and patient prognosis

      Varsha Tembe, Sarah-Jane Schramm, Mitchell S. Stark, Ellis Patrick, Vivek Jayaswal, Yue Hang Tang, Andrew Barbour, Nicholas K. Hayward, John F. Thompson, Richard A. Scolyer, Yee Hwa Yang and Graham J. Mann

      Article first published online: 5 JAN 2015 | DOI: 10.1111/pcmr.12343

      • image
      • image
      • image
      • image
      • image
      • image
  7. Microenvironment & Immunology (MEI)

    1. Original Articles

      PD-L1 expression in melanoma shows marked heterogeneity within and between patients: implications for anti-PD-1/PD-L1 clinical trials

      Jason Madore, Ricardo E. Vilain, Alexander M. Menzies, Hojabr Kakavand, James S. Wilmott, Jessica Hyman, Jennifer H. Yearley, Richard F. Kefford, John F. Thompson, Georgina V. Long, Peter Hersey and Richard A. Scolyer

      Article first published online: 22 DEC 2014 | DOI: 10.1111/pcmr.12340

      • image
      • image
      • image

VIEW

  1. 1 - 9

SEARCH

SEARCH BY CITATION